Is KEQU a good stock to buy right now?

Based on our 6-factor quantitative model, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) receives a "Reduce" rating with a composite score of 42.0/100. It is ranked #2,663 out of 4,446 stocks. Key factor scores: Quality 50/100, Value 47/100, Momentum 30/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for KEQU?

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a "Reduce" rating and 2-star score. The composite score of 42.0 ranks it #2,663 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is KEQU in?

KEWAUNEE SCIENTIFIC CORP /DE/ operates in the Technology sector (Measuring And Control Equipment industry) with a market cap of $97 million. It is classified as a micro-cap stock.

Does KEQU pay a dividend?

KEQU does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is KEQU's P/E ratio?

KEQU has a trailing P/E ratio of 11.95x. The Technology sector average is 45.3x. This below-average P/E may indicate the stock is undervalued.

How profitable is KEQU?

KEQU's quality factor score is 50/100. Gross margin: 27.9%. ROE: 11.3% vs sector average -1.4%. Margins are moderate to low, reflecting competitive market dynamics.

How is KEQU valued compared to peers?

KEQU's value factor score is 47/100 (higher = cheaper). Key multiples: P/E 11.9x, EV/EBITDA 8.6x. Valuation is roughly in line with peers.

What is KEQU's debt level?

KEQU's debt-to-equity ratio is 29%. Sector average: 43%. Low leverage suggests conservative financial management.

KEQU has a beta of 0.98, meaning it tracks the market. Stability score: 41/100.

Does KEQU have high short interest?

KEQU's short interest factor score is 61/100 (higher = less short selling). Moderate short interest.

KEQU Stock Analysis: Top Micro-Cap Reduce (Score 42.0/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
KEQU	+2.42%	+2.81%	-16.94%	-6.64%	+1.09%	-	-	-
Industry Proxy XLK	+0.39%	+4.88%	+2.05%	-0.94%	-26.62%	-	-	-
U.S. Market SPY	-0.07%	+3.60%	+0.34%	-0.36%	+29.52%	-	-	-
Alpha vs Market	+2.49%	-0.79%	-17.28%	-6.28%	-28.44%	-	-	-
Alpha vs Sector	+2.03%	-2.06%	-18.99%	-5.70%	+27.71%	-	-	-

Metric	KEQU	Benchmark
P/E Ratio	11.9x	-74%
EV/EBITDA	8.6x	-32%
Price / Book	1.3x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
VRSN VERISIGN INC/CA	56	79	59	40	30.3x	-41.1%	88.0%	50.6%	8.3%	-87.0x	$23.0B	VS
IHS IHS Holding Ltd	55	42	63	63	-	-616.0%	48.0%	-96.1%	-	365.0x	$2.8B	VS
LHX L3HARRIS TECHNOLOGIES, INC. /DE/	55	50	52	66	38.3x	9.0%	25.5%	8.1%	10.3%	110.0x	$66.1B	VS
ESP ESPEY MFG & ELECTRONICS CORP	53	48	44	71	26.3x	12.8%	29.0%	17.1%	-11.7%	66.0x	$169M	VS
NYAX Nayax Ltd.	52	38	46	78	-	-13.6%	44.6%	-1.8%	-	30.0x	$2.2B	VS
ESE ESCO TECHNOLOGIES INC	52	49	40	69	69.6x	7.4%	40.8%	10.4%	16.3%	9.0x	$7.6B	VS
INTT INTEST CORP	52	50	32	72	-	-3.2%	43.1%	-3.1%	-22.8%	46.0x	$179M	VS
KARO Karooooo Ltd.	49	50	72	53	-	117.1%	69.5%	20.3%	-	10.0x	$1.6B	VS
MTC MMTec, Inc.	47	32	40	96	-	-1,370.8%	81.6%	-4,879.7%	-	120.0x	$136M	VS
CCLD CareCloud, Inc.	47	38	71	60	11.9x	18.5%	48.0%	9.6%	10.6%	47.0x	$154M	VS
KEQU KEWAUNEE SCIENTIFIC CORP /DE/	42	50	47	30	12.0x	11.3%	27.9%	2.9%	45.3%	29.0x	$97M

Key Ratio	TTM	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin %	0.3%	0.3%	0.3%	0.3%	0.2%	0.1%	0.2%	0.2%	0.2%	0.2%	0.2%
Operating Margin %	0.0%	0.0%	0.1%	0.1%	0.0%	-0.0%	-0.0%	-0.0%	0.0%	0.1%	0.0%
EBITDA Margin %	0.0%	0.0%	0.1%	0.1%	0.0%	-0.0%	0.0%	0.0%	0.0%	0.1%	0.1%
Net Margin %	0.0%	0.0%	0.0%	0.1%	0.0%	-0.0%	-0.0%	-0.0%	0.0%	0.0%	0.0%
FCF Margin %	-	-	-	-	-	-	-1.0%	1.1%	-1.2%	-0.1%	6.5%
ROE %	0.1%	0.0%	0.2%	0.3%	0.0%	-0.2%	-0.1%	-0.1%	0.0%	0.1%	0.1%
ROA %	0.0%	0.0%	0.1%	0.1%	0.0%	-0.1%	-0.0%	-0.1%	0.0%	0.1%	0.1%
ROIC %	0.1%	2.2%	13.5%	25.7%	11.0%	-5.7%	-2.4%	-4.8%	3.5%	17.9%	13.8%

Key Ratio

TTM

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

Gross Margin %

0.3%

0.2%

0.1%

0.2%

Operating Margin %

0.0%

0.1%

0.0%

-0.0%

0.0%

0.1%

0.0%

EBITDA Margin %

0.0%

0.1%

0.0%

-0.0%

0.0%

0.1%

Net Margin %

0.0%

0.1%

0.0%

-0.0%

0.0%

FCF Margin %

-1.0%

1.1%

-1.2%

-0.1%

6.5%

ROE %

0.1%

0.0%

0.2%

0.3%

0.0%

-0.2%

-0.1%

0.0%

0.1%

ROA %

0.0%

0.1%

0.0%

-0.1%

-0.0%

-0.1%

0.0%

0.1%

ROIC %

0.1%

2.2%

13.5%

25.7%

11.0%

-5.7%

-2.4%

-4.8%

3.5%

17.9%

13.8%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
	$278M	$240M	$204M	$219M	$169M	$147M	$148M	$147M	$158M	$139M	$129M	$119M
	—	$172M	$152M	$184M	$145M	—	—	—	—	—	—	—
	$78M	$69M	$52M	$36M	$24M	$24M	$23M	$25M	$32M	$27M	$24M	$22M
Gross Margin	27.9%	28.6%	25.6%	16.2%	14.3%	16.3%	15.9%	17.3%	20.3%	19.2%	18.4%	18.3%
	—	$919K	$920K	$1M	$990K	—	—	—	—	—	—	—
Depreciation	—	—	—	—	—	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Total Operating Expenses	—	$51M	$34M	$30M	$27M	—	—	—	—	—	—	—
	$14M	$18M	$18M	$5M	-$3M	-$1M	-$2M	$2M	$10M	$7M	$6M	$5M
EBIT	$14M	$18M	$18M	$5M	-$3M	-$1M	-$2M	$2M	$10M	$7M	$6M	$5M
EBITDA	$14M	$18M	$18M	$5M	-$3M	$459K	$281K	$5M	$13M	$10M	$9M	$8M
Operating Margin	4.9%	7.4%	9.0%	2.4%	-1.5%	-0.9%	-1.6%	1.4%	6.3%	4.7%	4.4%	4.4%
EBITDA Margin	5.0%	7.4%	9.0%	2.4%	-1.5%	0.3%	0.2%	3.5%	8.0%	7.0%	6.7%	7.0%
	—	—	$2M	$2M	$632K	$389K	$493K	$367K	$299K	$292K	$306K	$325K
	—	$15M	$13M	$4M	-$2M	—	—	—	—	—	—	—
Income Tax Expense	—	$3M	-$6M	$3M	$4M	$990K	$2M	$446K	$4M	$2M	$2M	$2M
	$8M	$12M	$19M	$1M	-$6M	-$4M	-$5M	$2M	$5M	$5M	$4M	$4M
Net Margin	2.9%	4.8%	9.3%	0.6%	-3.5%	-2.5%	-3.1%	1.1%	3.5%	3.3%	3.0%	3.1%
	$0.24	$3.98	$6.51	$0.26	$-2.20	$-1.33	$-1.70	$0.56	$1.94	$1.67	$1.43	$1.34
Diluted EPS	$0.24	$3.83	$6.38	$0.25	$-2.20	$-1.33	$-1.70	$0.56	$1.94	$1.67	$1.43	$1.34
Weighted Avg Basic	—	3M	3M	3M	3M	—	—	—	—	—	—	—
Weighted Avg Diluted	—	3M	3M	3M	3M	—	—	—	—	—	—	—

Line Item

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

$278M

$240M

$204M

$219M

$169M

$147M

$148M

$147M

$158M

$139M

$129M

$119M

—

$172M

$152M

$184M

$145M

—

$78M

$69M

$52M

$36M

$24M

$23M

$25M

$32M

$27M

$24M

$22M

Gross Margin

27.9%

28.6%

25.6%

16.2%

14.3%

16.3%

15.9%

17.3%

20.3%

19.2%

18.4%

18.3%

—

$919K

$920K

$1M

$990K

—

Depreciation

—

$3M

Total Operating Expenses

—

$51M

$34M

$30M

$27M

—

$14M

$18M

$5M

-$3M

-$1M

-$2M

$2M

$10M

$7M

$6M

$5M

EBIT

$14M

$18M

$5M

-$3M

-$1M

-$2M

$2M

$10M

$7M

$6M

$5M

EBITDA

$14M

$18M

$5M

-$3M

$459K

$281K

$5M

$13M

$10M

$9M

$8M

Operating Margin

4.9%

7.4%

9.0%

2.4%

-1.5%

-0.9%

-1.6%

1.4%

6.3%

4.7%

4.4%

EBITDA Margin

5.0%

7.4%

9.0%

2.4%

-1.5%

0.3%

0.2%

3.5%

8.0%

7.0%

6.7%

7.0%

—

$2M

$632K

$389K

$493K

$367K

$299K

$292K

$306K

$325K

—

$15M

$13M

$4M

-$2M

—

Income Tax Expense

—

$3M

-$6M

$3M

$4M

$990K

$2M

$446K

$4M

$2M

$8M

$12M

$19M

$1M

-$6M

-$4M

-$5M

$2M

$5M

$4M

Net Margin

2.9%

4.8%

9.3%

0.6%

-3.5%

-2.5%

-3.1%

1.1%

3.5%

3.3%

3.0%

3.1%

$0.24

$3.98

$6.51

$0.26

$-2.20

$-1.33

$-1.70

$0.56

$1.94

$1.67

$1.43

$1.34

Diluted EPS

$0.24

$3.83

$6.38

$0.25

$-2.20

$-1.33

$-1.70

$0.56

$1.94

$1.67

$1.43

$1.34

Weighted Avg Basic

—

Weighted Avg Diluted

—

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does KEWAUNEE SCIENTIFIC CORP /DE/ Do?

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina. KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) is classified as a micro-cap stock in the Technology sector, specifically within the Measuring And Control Equipment industry. The company is led by CEO Thomas D. Hull and employs approximately 890 people, headquartered in Dover, North Carolina. With a market capitalization of $97M, KEQU is one of the notable companies in the Technology sector.

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) Stock Rating — Reduce (April 2026)

As of April 2026, KEWAUNEE SCIENTIFIC CORP /DE/ receives a Reduce rating with a composite score of 42.0/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.KEQU ranks #2,663 out of 4,446 stocks in our coverage universe. Within the Technology sector, KEWAUNEE SCIENTIFIC CORP /DE/ ranks #284 of 584 stocks, placing it in the upper half of its Technology peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

KEQU Stock Price and 52-Week Range

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) currently trades at $34.92. The stock gained $0.82 (2.4%) in the most recent trading session. The 52-week high for KEQU is $60.89, which means the stock is currently trading -42.6% from its annual peak. The 52-week low is $30.33, putting the stock 15.2% above its annual trough. Recent trading volume was 2K shares, suggesting relatively thin trading activity.

Is KEQU Overvalued or Undervalued? — Valuation Analysis

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) carries a value factor score of 47/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 11.95x, compared to the Technology sector average of 45.27x — a discount of 74%. The price-to-book ratio stands at 1.34x, versus the sector average of 3.16x. The price-to-sales ratio is 0.35x, compared to 1.06x for the average Technology stock. On an enterprise value basis, KEQU trades at 8.64x EV/EBITDA, versus 12.79x for the sector.

Overall, KEQU's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.

KEWAUNEE SCIENTIFIC CORP /DE/ Profitability — ROE, Margins, and Quality Score

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 11.3%, compared to the Technology sector average of -1.4%, which is within a healthy range. Return on assets (ROA) comes in at 4.6% versus the sector average of -1.0%.

On a margin basis, KEWAUNEE SCIENTIFIC CORP /DE/ reports gross margins of 27.9%, compared to 50.9% for the sector. The operating margin is 4.9% (sector: -0.5%). Net profit margin stands at 2.9%, versus -1.5% for the average Technology stock. Revenue growth is running at 45.3% on a trailing basis, compared to 14.2% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.

KEQU Debt, Balance Sheet, and Financial Health

KEWAUNEE SCIENTIFIC CORP /DE/ has a debt-to-equity ratio of 29.0%, compared to the Technology sector average of 43.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 2.12x, indicating strong short-term liquidity. Total debt on the balance sheet is $21M.

KEQU has a beta of 0.98, meaning it is roughly in line with the broader market in terms of price volatility. The stability factor score for KEWAUNEE SCIENTIFIC CORP /DE/ is 41/100, reflecting average volatility within the normal range for its sector.

KEWAUNEE SCIENTIFIC CORP /DE/ Revenue and Earnings History — Quarterly Trend

In TTM 2026, KEWAUNEE SCIENTIFIC CORP /DE/ reported revenue of $278M and earnings per share (EPS) of $0.24. Net income for the quarter was $8M. Gross margin was 27.9%. Operating income came in at $14M.

In Q3 2026, KEWAUNEE SCIENTIFIC CORP /DE/ reported revenue of $69M and earnings per share (EPS) of $0.24. Net income for the quarter was $1M. Gross margin was 26.7%. Revenue grew 3.3% year-over-year compared to Q3 2025. Operating income came in at $3M.

In Q2 2026, KEWAUNEE SCIENTIFIC CORP /DE/ reported revenue of $70M and earnings per share (EPS) of $0.85. Net income for the quarter was $3M. Gross margin was 28.1%. Revenue grew 46.8% year-over-year compared to Q2 2025. Operating income came in at $4M.

In Q1 2026, KEWAUNEE SCIENTIFIC CORP /DE/ reported revenue of $71M and earnings per share (EPS) of $1.08. Net income for the quarter was $3M. Gross margin was 29.4%. Revenue grew 46.9% year-over-year compared to Q1 2025. Operating income came in at $5M.

Over the past 8 quarters, KEWAUNEE SCIENTIFIC CORP /DE/ has demonstrated a growth trajectory, with revenue expanding from $48M to $278M. Investors analyzing KEQU stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

KEQU Dividend Yield and Income Analysis

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) does not currently pay a dividend. This is common among smaller companies in the Measuring And Control Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Technology dividend stocks may want to explore other Technology stocks or use the stock screener to filter by dividend yield.

KEQU Momentum and Technical Analysis Profile

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a momentum factor score of 30/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 23/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 61/100 reflects moderate short selling activity.

KEQU vs Competitors — Technology Sector Ranking and Peer Comparison

Within the Technology sector, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) ranks #284 out of 584 stocks based on the Blank Capital composite score. This places KEQU in the upper half of all Technology stocks in our coverage universe. Key competitors and sector peers include IHS Holding Ltd (IHS) with a score of 55.0/100, VERISIGN INC/CA (VRSN) with a score of 56.0/100, ESCO TECHNOLOGIES INC (ESE) with a score of 51.7/100, CareCloud, Inc. (CCLD) with a score of 46.9/100, and MMTec, Inc. (MTC) with a score of 47.4/100.

Comparing KEQU against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full KEQU vs S&P 500 (SPY) comparison to assess how KEWAUNEE SCIENTIFIC CORP /DE/ stacks up against the broader market across all factor dimensions.

KEQU Next Earnings Date

No upcoming earnings date has been announced for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy KEQU? — Investment Thesis Summary

The quantitative profile for KEWAUNEE SCIENTIFIC CORP /DE/ suggests caution. Momentum is weak at 30/100, a headwind for near-term performance.

In summary, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) earns a Reduce rating with a composite score of 42.0/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on KEQU stock.

Related Resources for KEQU Investors

Explore more research and tools: KEQU vs S&P 500 comparison, top Technology stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare KEQU head-to-head with peers: KEQU vs IHS, KEQU vs VRSN, KEQU vs ESE.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

Kewaunee Scientific (KEQU) Margin Compression To 4.1% Challenges Bullish Earnings Narratives

Kewaunee Earnings Decline Y/Y in Q3 Despite Sales Growth

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Technology Stocks

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) Stock Analysis — April 2026 Rating, Price, and Forecast

Company Overview — What Does KEWAUNEE SCIENTIFIC CORP /DE/ Do?

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) Stock Rating — Reduce (April 2026)

KEQU Stock Price and 52-Week Range

Is KEQU Overvalued or Undervalued? — Valuation Analysis

KEWAUNEE SCIENTIFIC CORP /DE/ Profitability — ROE, Margins, and Quality Score

KEQU Debt, Balance Sheet, and Financial Health

KEWAUNEE SCIENTIFIC CORP /DE/ Revenue and Earnings History — Quarterly Trend

KEQU Dividend Yield and Income Analysis

KEQU Momentum and Technical Analysis Profile

KEQU vs Competitors — Technology Sector Ranking and Peer Comparison

KEQU Next Earnings Date

Should You Buy KEQU? — Investment Thesis Summary

Related Resources for KEQU Investors

Comments

Institutional Benchmarks

Related research

Get alerted on rating changes

Intelligence Feed

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

Kewaunee Scientific (KEQU) Margin Compression To 4.1% Challenges Bullish Earnings Narratives

Kewaunee Earnings Decline Y/Y in Q3 Despite Sales Growth